Pioneering Biologics,Empowering Africa

Dedicated to making high-quality biologics accessible through localized innovation

1.5B+

Population Coverage

WHO PQ

Quality Standard

Green Energy

Self-Sufficient

In Africa, For Africa, To the World

Bridging the Gap. From "Import Dependent" to "Made in Africa"

Four Major Disease Areas

Comprehensive product coverage addressing Africa's critical health needs

Diabetes & Related

Semaglutide, Tirzepatide, Icodec Insulin, IcoSema

Cancer & Related

Bevacizumab, Rituximab, Trastuzumab, Adalimumab, PD-1

HIV Related

Lenacapavir, Long-acting antiretroviral therapies

Vaccines Related

HPV2-HPV9, PCV, Malaria vaccines

Strategic R&D Roadmap

Four-phase product pipeline strategy driving innovation across Africa

R&D Innovation Lab
Strategic Partnership

Partner with Tigermed to Build Clinical Trial Base in Africa

We are collaborating with Tigermed, a leading global CRO, to establish a state-of-the-art clinical trial center in Africa. This partnership will accelerate innovative drug development, enhance local research capabilities, and bring cutting-edge treatments to African patients faster.

Clinical Trial Base in Africa
Manufacturing Facility

Africa's First Green Pharma Facility

GMP, FDA, EMA & WHO PQ compliant

Ready to Learn More?

Discover how we're transforming healthcare across Africa through innovation and local production.